| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.29 | 0.07 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |